Regenerelle

Regenerelle is a biotechnology company specializing in the development and manufacturing of regenerative medicine products derived from human umbilical cord tissue. The company focuses on high-potency mesenchymal stem cells (MSCs) and acellular exosome therapies designed for applications in orthopedics, aesthetics, and systemic wellness. Operating out of a state-of-the-art facility, Regenerelle provides clinicians with standardized, off-the-shelf biologic solutions aimed at accelerating tissue repair and reducing inflammation. Their proprietary processing techniques ensure high concentrations of regenerative factors while maintaining strict safety and quality standards. The company's portfolio includes cellular grafts and extracellular vesicle products that support the body's natural healing processes.